DENTSPLY SIRONA Inc. XRAY is scheduled to release third ... The Zacks Consensus Estimate for EPS implies an improvement of 33.3% from the year-ago figure. ACADIA Pharmaceuticals ACAD has an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback